![Gérard Moxon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Gérard Moxon is the Managing Director of Technomark Group Ltd and a financier by background and training.
After degrees from Durham University and the London School of Economics, he joined Lloyds Bank International and served in Brazil, France and Portugal in a number of executive positions.
On returning to the UK in 1990, he joined Lloyds Private Banking, the elite private banking group of the Lloyds Bank Group.
In 1993 Mr Moxon joined Merrill Lynch in London as Vice-President and built up a team from nothing to more than $400 million under management from a number of high net worth individuals and institutions.
On leaving Merrill Lynch in 2002 Gérard Moxon served as an executive director of Stanford International Bank of Texas and London & Capital Asset Management before purchasing the majority shareholding in Technomark with Mark Horrocks in 2005.
Anciens postes connus de Gérard Moxon
| Sociétés | Poste | Fin |
|---|---|---|
Technomark Investment Management Ltd.
 Technomark Investment Management Ltd. Investment ManagersFinance TIM is an international venture capital investment manager following a hands-on approach with a long-term outlook. The firm invests in early-stage medical science companies throughout the UK and continental Europe, often with connections in Asia. They focus on sectors including drug development, outsourced R&D and manufacturing, medical devices, medical services, diagnostics and biotechnology. TIM's investment strategy consists in assessing the commercial potential of a given technology, and identifying or developing strong management teams. The firm sources deals through their extensive network in the pharmaceutical industry. They target projects in which they identify strong science with adequate IP protection, a clearly defined market with an achievable market share, a realistic technology development plan, and a strong management team. | President | 01/10/2008 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Technomark Investment Management Ltd.
Technomark Investment Management Ltd. Investment ManagersFinance TIM is an international venture capital investment manager following a hands-on approach with a long-term outlook. The firm invests in early-stage medical science companies throughout the UK and continental Europe, often with connections in Asia. They focus on sectors including drug development, outsourced R&D and manufacturing, medical devices, medical services, diagnostics and biotechnology. TIM's investment strategy consists in assessing the commercial potential of a given technology, and identifying or developing strong management teams. The firm sources deals through their extensive network in the pharmaceutical industry. They target projects in which they identify strong science with adequate IP protection, a clearly defined market with an achievable market share, a realistic technology development plan, and a strong management team. | Finance |
